Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1987 3
1988 4
1989 1
1990 3
1991 3
1992 9
1993 4
1994 9
1995 12
1996 8
1997 11
1998 9
1999 19
2000 24
2001 18
2002 18
2003 30
2004 41
2005 49
2006 46
2007 52
2008 40
2009 47
2010 33
2011 53
2012 31
2013 40
2014 61
2015 55
2016 52
2017 55
2018 75
2019 85
2020 101
2021 103
2022 42
Text availability
Article attribute
Article type
Publication date

Search Results

1,140 results
Results by year
Filters applied: . Clear all
Page 1
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial.
Giugliano RP, Pedersen TR, Park JG, De Ferrari GM, Gaciong ZA, Ceska R, Toth K, Gouni-Berthold I, Lopez-Miranda J, Schiele F, Mach F, Ott BR, Kanevsky E, Pineda AL, Somaratne R, Wasserman SM, Keech AC, Sever PS, Sabatine MS; FOURIER Investigators. Giugliano RP, et al. Among authors: park jg. Lancet. 2017 Oct 28;390(10106):1962-1971. doi: 10.1016/S0140-6736(17)32290-0. Epub 2017 Aug 28. Lancet. 2017. PMID: 28859947 Free article. Clinical Trial.
Structural basis of RNA cap modification by SARS-CoV-2.
Viswanathan T, Arya S, Chan SH, Qi S, Dai N, Misra A, Park JG, Oladunni F, Kovalskyy D, Hromas RA, Martinez-Sobrido L, Gupta YK. Viswanathan T, et al. Among authors: park jg. Nat Commun. 2020 Jul 24;11(1):3718. doi: 10.1038/s41467-020-17496-8. Nat Commun. 2020. PMID: 32709886 Free PMC article.
Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.
Ye C, Chiem K, Park JG, Oladunni F, Platt RN 2nd, Anderson T, Almazan F, de la Torre JC, Martinez-Sobrido L. Ye C, et al. Among authors: park jg. mBio. 2020 Sep 25;11(5):e02168-20. doi: 10.1128/mBio.02168-20. mBio. 2020. PMID: 32978313 Free PMC article.
Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice.
Oladunni FS, Park JG, Pino PA, Gonzalez O, Akhter A, Allué-Guardia A, Olmo-Fontánez A, Gautam S, Garcia-Vilanova A, Ye C, Chiem K, Headley C, Dwivedi V, Parodi LM, Alfson KJ, Staples HM, Schami A, Garcia JI, Whigham A, Platt RN 2nd, Gazi M, Martinez J, Chuba C, Earley S, Rodriguez OH, Mdaki SD, Kavelish KN, Escalona R, Hallam CRA, Christie C, Patterson JL, Anderson TJC, Carrion R Jr, Dick EJ Jr, Hall-Ursone S, Schlesinger LS, Alvarez X, Kaushal D, Giavedoni LD, Turner J, Martinez-Sobrido L, Torrelles JB. Oladunni FS, et al. Among authors: park jg. Nat Commun. 2020 Nov 30;11(1):6122. doi: 10.1038/s41467-020-19891-7. Nat Commun. 2020. PMID: 33257679 Free PMC article.
Intermittent fasting promotes adipose thermogenesis and metabolic homeostasis via VEGF-mediated alternative activation of macrophage.
Kim KH, Kim YH, Son JE, Lee JH, Kim S, Choe MS, Moon JH, Zhong J, Fu K, Lenglin F, Yoo JA, Bilan PJ, Klip A, Nagy A, Kim JR, Park JG, Hussein SM, Doh KO, Hui CC, Sung HK. Kim KH, et al. Among authors: park jg. Cell Res. 2017 Nov;27(11):1309-1326. doi: 10.1038/cr.2017.126. Epub 2017 Oct 17. Cell Res. 2017. PMID: 29039412 Free PMC article.
Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).
Giugliano RP, Cannon CP, Blazing MA, Nicolau JC, Corbalán R, Špinar J, Park JG, White JA, Bohula EA, Braunwald E; IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) Investigators. Giugliano RP, et al. Among authors: park jg. Circulation. 2018 Apr 10;137(15):1571-1582. doi: 10.1161/CIRCULATIONAHA.117.030950. Epub 2017 Dec 20. Circulation. 2018. PMID: 29263150 Clinical Trial.
1,140 results